Seeking Alpha

PennyStockHaven's  Instablog

PennyStockHaven
Send Message
Covering Small & Micro Cap Equities listed on the NYSE, NASDAQ, and OTC markets. We track hundreds of companies on a daily basis, analyzing intrinsic and price-related variables. Follow our research and coverage on our site at http://pennystockhaven.com/
My company:
PennyStockHaven
My blog:
Penny Stock Haven
  • Daytrading ImmunoGen, Inc. (Nasdaq: IMGN) 0 comments
    Apr 7, 2011 10:37 PM | about stocks: IMGN

    ImmunoGen, Inc. (Nasdaq: IMGN) released news that its experimental therapy for breast cancer achieved positive phase 2 trial results. The results showed that new ImmunoGen's therapy could potentially be more effective than a combination of Herceptin and chemotherapy, which is the current standard of care for many HER2-positive breast cancer patients.

    IMGN surged on this news & rumor of the potential buyout. So far IMGN offered excellent daytrading opportunity (chart below)
    IMGN daily chart
     

    Themes: biopharma Stocks: IMGN
Back To PennyStockHaven's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • $CLGL drilling program starts in April
    Mar 23, 2012
More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.